 |
 | -20°C |  | Ambient |  | Hazardous |  | Highly Toxic & Carcinogenic / Teratogenic | | Note: Store and Ship conditions may differ. | | See Key |
|
 |
 |
 |
| | Phosphatase Inhibitor Cocktail Set I | |  | Cat. No. 524624 | |
Liquid. In DMSO. A cocktail of three inhibitors that will inhibit alkaline phosphatases as well as serine/threonine protein phosphatases such as PP1 and PP2A. This product is provided as a set of five 1 ml vials. Each vial contains 1 ml phosphatase inhibitor cocktail solubilized in DMSO with the following components: Bromotetramisole oxalate (2.5 mM), Cantharidin (Cat. No. 210155; 500 µM), and Microcystin-LR (Cat. No. 475815; 500 nM). R: 26/27/28-36/37/38-40-43; S: 26-36/37/39-45-23 Not available for sale outside of the United States. |
| Related information for this product is available: | |
| |
EMD Chemicals Inc. USD list price is displayed (pricing with local distributors may vary). NOTE: In Stock status is based on item availability worldwide.
 | - Takeshi Shimamura, et al. (2005) Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins. Cancer Research 65, 6401-6408.
|  |
|
|